New challenges and the state of development of COVID-19 in connection with the spread of new strains of SARS-CoV-2 have been analyzed. Experience and knowledge in working with new means of protection of different types of vaccines are studied: both classic, based on inactivated virus or its fragment, and the new generation - with vector and genetic mRNA vaccines, as well as effective antiviral drugs. Biorisks and compliance with biosafety principles have been studied. The replenishment of the base of competencies for biotechnologists and pharmacists in the context of distance learning and response to the pandemic is considered. The new data were used to introduce and deepen knowledge about the new generation of vaccines and the dangers of dual use of experimental data in the development of new components of educational programs in "Biotechnology and Bioengineering" and “Pharmacy, Industrial Pharmacy”.
1. Nakaz Ministerstva osvity i nauky № 406 vid 16.03.2020 "Pro orhanizatsiini zakhody shchodo zapobihannia poshyrenniu koronavirusu COVID-19" https://osvita.ua/legislation/other/71755/
2. Pro zatverdzhennia protyepidemichnykh zakhodiv u navchalnykh zakladakh na period karantynu u zviazku z poshyrenniam koronavirusnoi khvoroby (COVID-19). Postanova MOZ № 50 vid 22.08.2020 http://osvita.ua/legislation/other/76059/
3. Thirumalaisamy P. Velavan, Christian G. Meyer. The COVID‐19 epidemic // Tropical Medicine and International ealth. 2020. V. 25(3). P. 278-280. doi: 10.1111/tmi.13383
https://doi.org/10.1111/tmi.13383
4. Prozorro (2021) https://prozorro.gov.ua/tender/UA-2021-04-29-001526-a
5. Shved, O. V., Petrina, R. O., Hubytska, I. I., Bolobruch, L. D., Skorokhoda, V. Yu., Novikov, V. P. (2020). Hotovnist do vyklykiv virusnoi infektsii ta zastosuvannia studentamy znan biobezpechnykh tekhnolohii. Khimiia, tekhnolohiia ta zastosuvannia rechovyn, 3 (1), 95-109. doi: 10.23939/ctas2020.01.095
https://doi.org/10.23939/ctas2020.01.095
6. Marik, P. (2021). COVID 19: A Clinical Update. http://surl.li/ypfe
7. Challen, R., Brooks-Pollock, E, . Read, J. M., Dyson, L., Tsaneva-Atanasova, K., Danon, L. (2021). Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study. BMJ, 372, 579. doi:10.1136/bmj.n579
https://doi.org/10.1136/bmj.n579
8. (2021). In the UK, cases of the Covid variant identified in India double in one week.
https://www.cnbc.com/2021/05/28/uk-cases-of-covid-variant-identified-in-...
9. Ukrinform (2021). Ukrainski vcheni rozpovily pro nebezpeku mutatsii u "brytanskomu" shtami. https://www.ukrinform.ua/rubric-society/3212716-ukrainski-vceni-rozpovil...
10. Prymamed (2021). Otsiny svii imunitet do COVID-19. https://primamed.if.ua/otsiny-svii-imunitet-do-covid-19/
11. Synevo (2021). Testy na COVID-19 u Synevo. https://covid19.synevo.ua
12. Clinical care for severe acute respiratory infection. Tools. Adapted to COVID-19. Copenhagen: World Health Organization, Regional European Office; 2020 (WHO/2019- nCoV/SARI_toolkit/2020.1). CC BY-NC-SA 3.0 IGO.
13. Kolisnyk Yu. (2020). Koronavirus SARSCoV-2: test na tsyvilnu vidpovidalnist. https://man.rv.ua/news/koronavirus-sarscov-2-test-hromadians-koi-vidpovi...
14. YuNISEF (2021). YuNISEF postavliaie v Ukrainu novu partiiu vaktsyny Pfizer: 473 850 doz pid COVAX. https://www.unicef.org/ukraine/press-releases/unicef-shipping-another-47...
15. Ministerstvo okhorony zdorovia Ukrainy (2021 r.). Pravo na vizd v Ukrainu daie povnyi kurs shcheplennia proty COVID-19 tilky skhvalenoiu VOOZ vaktsynoiu. https://bit.ly/3cKSqFK